United States PSMA PET Imaging Market is expected to reach US$ 2.0 billion by 2030 | Top Companies - Novartis Pharmaceuticals Corporation, Lantheus company, RadioMedix.

Market Size and Forecast:

The Global PSMA PET Imaging Market size reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.0 billion by 2030, growing with a CAGR of 3% during the forecast period 2024-2031. The Market growth is driven by the increasing prevalence of prostate cancer and rising adoption of advanced diagnostic imaging techniques for accurate disease detection and monitoring. According to DataM Intelligence

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/psma-pet-imaging-market?sz

The PSMA PET Imaging Market focuses on diagnostic imaging technologies that utilize Prostate-Specific Membrane Antigen (PSMA) ligands combined with positron emission tomography (PET) to detect prostate cancer. This advanced imaging method enhances accuracy in locating tumors, assessing metastasis, and guiding personalized treatment decisions, significantly improving early detection and disease management outcomes in prostate cancer patients.

Industry Recent Developments: United States

✅ October 2025: The U.S. market has seen robust growth attributed to the continued expansion of PSMA PET imaging adoption, driven by an increasing focus on advanced hybrid imaging technologies that integrate PET with CT or MRI for enhanced diagnostic accuracy in prostate cancer detection and therapy planning.

✅ September 2025: The market is witnessing strategic launches and broader clinical use of novel PSMA-targeted radiopharmaceuticals, enabling improved sensitivity and specificity in prostate cancer imaging and supporting the shift toward personalized medicine approaches in the U.S..

✅ August 2025: Mergers and collaborations among leading device manufacturers and pharmaceutical companies have accelerated innovation in radiopharmaceutical development, with North America retaining dominance due to high healthcare infrastructure and adoption of advanced imaging modalities.

Industry Recent Developments: Japan

✅ October 2025: Fujifilm Healthcare introduced a new AI-assisted MRI imaging platform for prostate cancer, enhancing diagnostic accuracy through advanced multiparametric analysis and better differentiation of malignant lesions.

✅ September 2025: Canon Medical Systems launched a PET/CT scanner powered by deep learning designed for prostate cancer staging and therapy response, markedly improving lesion detection sensitivity while reducing radiation exposure.

✅ October 2025: Curium Group, PeptiDream, and PDRadiopharma enrolled their first patient in a registrational clinical trial for 64Cu-PSMA-I&T, representing progress in expanding available PSMA-targeted radiopharmaceuticals for prostate cancer imaging in Japan.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/psma-pet-imaging-market?sz

FDA Approvals & Major Regulatory Actions (2025):

✅ Telix - FDA approval of Gozellix (TLX007-CDx, 68Ga gozetotide kit) - approved March 20-21, 2025 for PSMA-PET imaging in men with suspected metastasis or recurrence.

✅ Illuccix (gozetotide) - European / UK regulatory approvals (early 2025) - Telix received a positive EMA decision / European approval (MAA) in 17 Jan 2025 and the UK MHRA authorization was announced 12 Feb 2025 (government release). These expand PSMA-PET availability in Europe/UK.

✅ FDA regulatory activity for Lantheus (piflufolastat / Pylarify formulations) - Lantheus announced FDA acceptance of an NDA for a new formulation of piflufolastat F-18 (Pylarify / 18F-DCFPyL) with a PDUFA target date set (announcement Aug 6, 2025). (This is an agency acceptance / PDUFA scheduling event in 2025 rather than an approval in 2025.)

Mergers & Acquisitions (2025):

✅ Lantheus - acquisition activity (2025)
Completed Life Molecular Imaging acquisition (closed July 2025; announced/covered in 2025); Lantheus also completed the earlier acquisition of Evergreen Theragnostics in 2025 - both deals expand Lantheus' radiopharmaceutical and PET capabilities.

✅ Curium - capacity / footprint deals (2025)
Curium acquired Nucleis (GMP PET radiopharmaceutical manufacturer) - announced/completed 10 Apr 2025, strengthening PET manufacturing and distribution capacity in Europe. Curium also made other PET-capacity moves in 2025 (e.g., Monrol).

✅ Deal-level competition/regulatory scrutiny - some proposed radiopharma deals drew antitrust attention in Europe later in 2025 (e.g., Spanish CNMC decisions around Curium/IRAB in Oct 2025), illustrating regulators' sensitivity to consolidation in PET supply/manufacturing. (This is a related regulatory development signaling tighter review of PET-market M&A.)

Major Key Players:

Novartis Pharmaceuticals Corporation
Lantheus company
RadioMedix
Clarity Pharmaceuticals
Blue Earth Diagnostics, Inc.
Siemens Medical Solutions USA, Inc.
Eckert & Ziegler
Telix Pharmaceuticals
Canon Medical Systems, USA
Jubilant Draximage Radiopharmacies, Inc.

Segments Covered in the PSMA PET Imaging Market:

By Technology: Gallium-68 (Ga-68) PSMA PET Imaging, Fluorine-18 (F-18) PSMA PET Imaging.

By End-User: Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research and Academic Centers.

Regional Analysis for PSMA PET Imaging Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=psma-pet-imaging-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, PSMA PET Imaging market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global PSMA PET Imaging Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global PSMA PET Imaging market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the PSMA PET Imaging Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of PSMA PET Imaging market?

➠ Who are the global key manufacturers of the PSMA PET Imaging Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the PSMA PET Imaging market opportunities and threats faced by the vendors in the global PSMA PET Imaging Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the PSMA PET Imaging market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.